Genomics and Precision Medicine: Marketing Challenges and Opportunities

Jul 19, 2016

In an age of big data, companies now have more power to respond to their customers as individuals. Ever since the first internet shops discovered that tracking users’ buying habits could help them to predict what other products users might be interested in, a personalised and tailored service is something companies strive to deliver and consumers increasingly expect. Within this editorial, Jan Van den Burg at Veeva Systems shares his thoughts on genomics and precision medicine, reflecting on marketing challenges and opportunities. ...

Read More

Systemic Epigenetic Biomarkers for ALS Improve Early Diagnosis, Treatment, and Trials

Jul 19, 2016

Amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease is a devastating, rapidly progressive and invariably fatal neurological disease that attacks the nerve cells responsible for controlling voluntary muscles and for which there is no diagnostic or prognostic test. The disease belongs to a group of disorders known as motor neuron diseases (MNDs), characterised by the gradual degeneration and death of motor neurons. ALS is one of the most common neuromuscular diseases worldwide, affecting around 2 in 100,000 people each year. Magdalena Jeznach, BSc MSc, ALS Project Manager at Oxford Biodynamics Ltd, focuses on systemic epigenetic biomarkers for ALS. ...

Read More